These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 556564)

  • 1. Interactions of immune complexes and platelets in rabbits immunized with hapten-carrier conjugates.
    Kekomäki R; Kauppinen HL; Penttinen K; Myllylä G
    Acta Pathol Microbiol Scand C; 1977 Jun; 85(3):207-14. PubMed ID: 556564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistence of hapten-antibody complexes in the circulation of immunized animals after a single intravenous injection of hapten.
    Schmidt DH; Kaufman BM; Butler VP
    J Exp Med; 1974 Feb; 139(2):278-94. PubMed ID: 4129823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hapten concentrations in the circulation of animals actively immunized with hapten-protein conjugates.
    O'Neill SP; Robb TE
    J Immunol; 1976 Feb; 116(2):363-6. PubMed ID: 1249418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet aggregation and release associated with immune complex formation in pig plasma.
    Clark WF; Tevaarwerk GJ; Bandali K; Lindsay RM; Linton AL
    J Lab Clin Med; 1980 Oct; 96(4):654-65. PubMed ID: 7419956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival of rabbit platelets exposed to immune complexes.
    Parbtani A; Kinlough-Rathbone RL; Chahil A; Richardson M; Mustard JF
    Exp Mol Pathol; 1990 Feb; 52(1):109-21. PubMed ID: 2307208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immune response against hapten-autologous protein conjugates in the mouse.
    Rubin B; Wigzell H
    J Exp Med; 1973 Apr; 137(4):911-31. PubMed ID: 4540327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of human platelets in PRP via their Fc-receptor by antigen-antibody complexes or immunoglobulin G: requirement for particle-bound fibrinogen.
    Pfueller SL; Cosgrove LJ
    Thromb Res; 1980 Oct; 20(1):97-108. PubMed ID: 7209875
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug-antibody-platelet interaction in quinine- and quinidine-induced thrombocytopenia.
    Christie DJ; Aster RH
    J Clin Invest; 1982 Nov; 70(5):989-98. PubMed ID: 6215430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms underlying binding of immune complexes to macrophages.
    Phillips-Quagliata JM; Levine BB; Quagliata F; Uhr JW
    J Exp Med; 1971 Mar; 133(3):589-601. PubMed ID: 5111442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photochemical linking of primary aromatic amines to carrier proteins to elicit antibody response against the amine haptens.
    Pandey RN; Davis LE; Anderson B; Hollenberg PF
    J Immunol Methods; 1986 Nov; 94(1-2):237-46. PubMed ID: 3782813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence of synthesis by Lumbricus terrestris of specific substances in response to an immunization with a synthetic hapten.
    Laulan A; Morel A; Lestage J; Delaage M; Châteaureynaud-Duprat P
    Immunology; 1985 Dec; 56(4):751-8. PubMed ID: 4077104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed hypersensitivity to hapten-protein conjugates. II. Anti-hapten specificity and the heterogeneity of the delayed response.
    SILVERSTEIN AM; GELL PG
    J Exp Med; 1962 May; 115(5):1053-64. PubMed ID: 13912955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Requirements for antibody in the immune complex-induced platelet aggregation reaction.
    Palosuo T; Hurme M
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1973 Feb; 81(1):143-9. PubMed ID: 4125693
    [No Abstract]   [Full Text] [Related]  

  • 14. Aggregation of human blood platelets by immune complexes in the sedimentation pattern test.
    Myllylä G
    Scand J Haematol Suppl; 1973; 19():1-56. PubMed ID: 4127837
    [No Abstract]   [Full Text] [Related]  

  • 15. Carrier function in anti-hapten immune responses. II. Specific properties of carrier cells capable of enhancing anti-hapten antibody responses.
    Paul WE; Katz DH; Goidl EA; Benacerraf B
    J Exp Med; 1970 Aug; 132(2):283-99. PubMed ID: 4101345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The secondary immune response to a hapten in vitro. Antigen concentration and the carrier effect.
    Klinman NR
    J Exp Med; 1971 May; 133(5):963-72. PubMed ID: 4101805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carrier and hapten functions in immune deviation. II. Role of hapten and carrier on the helper functions of the T cells.
    Neveu PJ; Borduas AG
    Immunology; 1975 Mar; 28(3):553-9. PubMed ID: 47838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and identification of antigenic conjugates of podophyllotoxin.
    Xu DM; Yu XY; Liu YQ; Feng JT; Ma JQ; Liu XJ; Zhang X
    Yao Xue Xue Bao; 2005 Jun; 40(6):518-24. PubMed ID: 16144316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of antithymocyte globulin and other immune reactants on human platelets.
    Rosenberg JC; Lekas N; Lysz K; Morrell R
    Surgery; 1975 Apr; 77(4):520-9. PubMed ID: 1096340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SOluble and insoluble immune complex-platelet interactions in rheumatoid inflammation.
    Yeatts RP; Turner R; Collins R; Kaufmann J; Mashburn H
    Ann Rheum Dis; 1978 Oct; 37(5):421-7. PubMed ID: 718274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.